FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Rudelius Robert James 		2. Issuer Name and Ticker or Trading Symbol

ProUroCare Medical Inc. [ PUMD ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

__ X __ Director                      _____ 10% Owner
_____ Officer (give title below)      _____ Other (specify below)
(Last)          (First)          (Middle)

800 4TH STREET SW, #N821 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/20/2012
(Street)

WASHINGTON, DC 20024
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common stock, $0.00001 par value                  34756   I   By Noble Ventures, of which reporting person is the majority owner.  
Common stock, $0.00001 par value   6/20/2012     A (3)    7250   A $1.00   110205   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options   $2.90                      (1) 6/12/2014   Common Stock, $0.00001 par value   3000     3000   D    
Stock options   $1.00                      (1) 8/12/2015   Common stock, $0.00001 par value   1000     1000   D    
Warrants   $0.50                      (1) 12/31/2012   Common Stock, $0.00001 par value   4000     4000   D    
Warrants   $0.50                      (1) 12/31/2012   Common stock, $0.00001 par value   2000     2000   I   By Noble Ventures, of which reporting person is the majority owner  
Stock Options   $0.85                      (1) 3/3/2016   Common stock, $0.00001 par value   20000     20000   D    
Stock options   $1.25                      (1) 8/11/2016   Common stock, $0.00001 par value   1000     1000   D    
Stock Options   $1.50                      (1) 9/29/2016   Common stock, $0.00001 par value   30000     30000   D    
Warrants   $1.30                      (1) 1/7/2014   Common stock, $0.00001 par value   19986     19986   D    
Warrants   $1.30                      (1) 11/12/2012   Common stock, $0.00001 par value   10000     10000   D    
Warrants   $1.30                      (1) 7/12/2013   Common stock, $0.00001 par value   10000     10000   I   Held by Noble Ventures, of which reporting person is the majority owner.  
Warrants   $1.30                      (1) 11/12/2012   Common stock, $0.00001 par value   4756     4756   I   By Noble Ventures, of which reporting person is majority owner.  
Warrants   $1.30                      (1) 8/2/2013   Common stock, $0.00001 par value   10000     10000   I   By Noble ventures, of which reporting person is majority owner  
Warrants   $1.30                      (1) 8/2/2010   Commons stock, $0.00001 par value   10000     10000   D    
Options   $1.72                      (1) 8/10/2017   Common stock, $0.00001 par value   14535     14535   D    
Stock options   $0.87                      (2) 8/9/2018   Common stock, $0.00001 par value   28736     28736   D    
Convertible Note   $1.10                      (1) 8/28/2012   Common stock, $0.00001 par value     (4)   $6400   D    

Explanation of Responses:
( 1)  Currently exercisable
( 2)  Annual option award pursuant to the Issuer's compensation policy for Directors upon their re-election to the Board of Directors at its annual shareholders' meeting. The seven-year options vest ratably over 12 months.
( 3)  Shares issued in lieu of cash for directors' fees as approved by the Board of Directors which are exempt under section 16b-3(d).
( 4)  On December 1, 2011, the reporting person and the Company executed a convertible promissory note in the principal amount of $6,400 with a maturity date of February 28, 2012. The maturity date was subsequently changed to August 28, 2012. The principal amount and interest accruing at a rate of 10% per year are convertible into common shares at $1.10 per share at any time through the maturity date. The number of shares to be issued upon conversion will be fixed on the conversion date and reported on a Form 4 within 2 business days after conversion. The issuer's Board of Directors specifically approved the transaction as exempt from the requirements of Section 16b as provided by Rules 16b-3(d).

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Rudelius Robert James
800 4TH STREET SW
#N821
WASHINGTON, DC 20024 		X



Signatures
Richard B. Thon by power of attorney 6/26/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.
ProUroCare Medical (CE) (USOTC:PUMD)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more ProUroCare Medical (CE) Charts.